Pd-1 Antibody Combined Neoadjuvant Chemotherapy for Locally Advanced Cervical Cancer
Clinical trial NCT04516616 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04516616
- Sponsor
- Huazhong University of Science and Technology
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-01
- Primary completion
- 2023-04-30
- Enrollment
- 85
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.